Skip navigation

Chemical alosetron

Name alosetron
CAS Type 1 Name 1H-pyrido(4,3-b)indol-1-one, 2,3,4,5-tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-
Equivalent Terms 2,3,4,5-tetrahydro-5-methyl-2-((5-methylimidazol-4-yl)methyl)-1H-pyrido(4,3-b)indol-1-one monohydrochloride | alosetron hydrochloride | alosetron monohydrochloride | GR68755 | GR 68755 | Lotronex
CAS Registry Number 122852-42-0
Structure alosetron
Top Interacting
Genes
MeSH® ID C090840
External Links

Top ↑ Ancestors

1. ChemicalsHeterocyclic Compounds Has associated genes Has associated diseases Has associated exposure references Heterocyclic Compounds, 1-Ring Has associated genes Has associated diseases Has associated exposure references Pyridines Has associated genes Has associated diseases Has associated exposure references Carbolines Has associated genes Has associated diseases Has associated exposure references alosetron Has associated genes Has associated diseases
2. ChemicalsHeterocyclic Compounds Has associated genes Has associated diseases Has associated exposure references Heterocyclic Compounds, Fused-Ring Has associated genes Has associated diseases Has associated exposure references Heterocyclic Compounds, 2-Ring Has associated genes Has associated diseases Has associated exposure references Indoles Has associated genes Has associated diseases Has associated exposure references Carbolines Has associated genes Has associated diseases Has associated exposure references alosetron Has associated genes Has associated diseases
3. ChemicalsHeterocyclic Compounds Has associated genes Has associated diseases Has associated exposure references Heterocyclic Compounds, Fused-Ring Has associated genes Has associated diseases Has associated exposure references Heterocyclic Compounds, 3-Ring Has associated genes Has associated diseases Has associated exposure references Carbolines Has associated genes Has associated diseases Has associated exposure references alosetron Has associated genes Has associated diseases

Top ↑ Descendants

None.